These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26234088)

  • 21. [Lung and autoimmune disease--therapy].
    Hauber HP; Zabel P
    Dtsch Med Wochenschr; 2007 Aug; 132(33):1703-6. PubMed ID: 17713868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Musculoskeletal manifestations and autoimmune diseases related to new biologic agents.
    Haraoui B; Keystone E
    Curr Opin Rheumatol; 2006 Jan; 18(1):96-100. PubMed ID: 16344625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
    Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
    Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is B Cell-Targeted Therapy Effective in Systemic Lupus Erythematosus?
    Paran D; Naparstek Y
    Isr Med Assoc J; 2015 Feb; 17(2):98-103. PubMed ID: 26223085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
    Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematopoietic stem cell transplantation in autoimmune diseases in rheumatology practice].
    Kozák T; Becvár R; Havrdová E; Pitha J; Gregora E; Pytlík R; Maaloufová J; Kobylka P; Vodvárková S
    Cas Lek Cesk; 2000 Jun; 139(11):329-33. PubMed ID: 10953411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of microRNAs in the pathogenesis of autoimmune diseases.
    Chen JQ; Papp G; Szodoray P; Zeher M
    Autoimmun Rev; 2016 Dec; 15(12):1171-1180. PubMed ID: 27639156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biological therapies in systemic lupus erythematosus].
    Cairoli E; Espinosa G; Cervera R
    Rev Med Chil; 2010 Jul; 138(7):881-7. PubMed ID: 21043085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Specific antibodies of soluble nuclear antigens in autoimmune vasculitis].
    Weill BJ; Job-Deslandre C; Menkès CJ; Amor B
    Rev Rhum Mal Osteoartic; 1987 Jun; 54(6):453-6. PubMed ID: 3303286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell targeted therapies in rheumatoid arthritis and systemic lupus erythematosus.
    Eisenberg R; Albert D
    Nat Clin Pract Rheumatol; 2006 Jan; 2(1):20-7. PubMed ID: 16932648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of antibodies to histones in human systemic lupus erythematosus and in murine lupus-like syndromes using micro-ELISA.
    Costa O; Monier JC
    Ann Immunol (Paris); 1983; 134C(3):365-76. PubMed ID: 6605109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The weight of interleukin-6 in B cell-related autoimmune disorders.
    Youinou P; Jamin C
    J Autoimmun; 2009; 32(3-4):206-10. PubMed ID: 19307104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum and synovial fluid inhibitors of antibody-mediated lymphocytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.
    Arthritis Rheum; 1976; 19(2):142-9. PubMed ID: 56939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Immunomodulation therapy for autoimmune diseases. New hope for patients with autoimmune diseases].
    Szegedi G
    Orv Hetil; 2005 Apr; 146(14):635-43. PubMed ID: 15889537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases.
    Gottenberg JE; Guillevin L; Lambotte O; Combe B; Allanore Y; Cantagrel A; Larroche C; Soubrier M; Bouillet L; Dougados M; Fain O; Farge D; Kyndt X; Lortholary O; Masson C; Moura B; Remy P; Thomas T; Wendling D; Anaya JM; Sibilia J; Mariette X;
    Ann Rheum Dis; 2005 Jun; 64(6):913-20. PubMed ID: 15550531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systemic autoimmune diseases complicated with hydrocephalus: pathogenesis and management.
    Wei J; Yin H; Wang L; Cui L; Wang R
    Neurosurg Rev; 2019 Jun; 42(2):255-261. PubMed ID: 29130124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Autoantibodies to the heterogeneous nuclear ribonucleoproteins and the autoimmune diseases].
    Yang L; Yu M; Yang C
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Aug; 21(4):311-4. PubMed ID: 12567457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review.
    Lee KH; Kronbichler A; Park DD; Park Y; Moon H; Kim H; Choi JH; Choi Y; Shim S; Lyu IS; Yun BH; Han Y; Lee D; Lee SY; Yoo BH; Lee KH; Kim TL; Kim H; Shim JS; Nam W; So H; Choi S; Lee S; Shin JI
    Autoimmun Rev; 2017 Nov; 16(11):1160-1173. PubMed ID: 28899799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanisms of action of intravenous immunoglobulin therapy and potential use in autoimmune connective tissue diseases.
    Ballow M
    Cancer; 1991 Sep; 68(6 Suppl):1430-6. PubMed ID: 1878841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.